Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6178033 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TDP1MEN1THRBHTT | |
| SCHEMBL1050022 | 0.97 | — | — | |
| SCHEMBL3794820 | 0.92 | ALDH1A1 (0.34) | ALDH1A1MEN1THRBHTTKMT2A | |
| SCHEMBL5362 | 0.92 | — | — | |
| SCHEMBL8384094 | 0.86 | CYP3A4 (0.33) | ALDH1A1MEN1THRBHTTKMT2A | |
| SCHEMBL5708976 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TDP1MEN1THRBHTT | |
| SCHEMBL20314605 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TDP1MEN1THRBHTT | |
| SCHEMBL10816193 | 0.82 | TSHR (0.30) | — | |
| SCHEMBL9691389 | 0.81 | ALDH1A1 (0.39) | ALDH1A1TDP1MEN1THRBHTT | |
| SCHEMBL95923 | 0.81 | ALDH1A1 (0.39) | ALDH1A1TDP1MEN1THRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |